Symbol | Exchange | Currency |
|---|
April 23 (Reuters) - Analytica Ltd ALT.AX :* ANALYTICA LTD- ANNOUNCE A SHARE PLACEMENT AT AN ISSUE PRICE OF 0.35 CENTS PER SHARE WHICH WILL RAISE UP TO $3.83 MILLION
April 20 (Reuters) - Analytica Ltd ALT.AX :* ANALYTICA ANNOUNCES MIDDLE EAST MARKETING DISTRIBUTION AGREEMENT FOR EIS SYSTEM
March 30 (Reuters) - Analytica Ltd ALT.AX :* ENTERED JVA TO MANUFACTURE, DISTRIBUTE AND MARKET SYSTEM IN CHINA, MACAU, HONG KONG AND TAIWAN
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Neutral |
| Technical Indicators | Buy | Strong Buy | Buy | Buy | Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2.78 | 2.82 | 2.74 | -0.020 | -0.71% | 31.48M | Sydney | |||
| 0.605 | 0.00 | 0.00 | +0.040 | +7.08% | 1.88M | Sydney | |||
| 55.81 | 56.17 | 54.66 | +1.70 | +3.14% | 285.15K | Sydney | |||
| 103.69 | 105.40 | 103.69 | -2.220 | -2.10% | 8.44M | Sydney | |||
| 15.10 | 15.51 | 15.01 | -0.10 | -0.66% | 1.75M | Sydney | |||
| 23.60 | 23.99 | 23.60 | -0.12 | -0.51% | 267.11K | Sydney | |||
| 2.28 | 2.28 | 2.22 | +0.060 | +2.70% | 13.75K | Sydney | |||
| 22.42 | 22.70 | 22.12 | -0.190 | -0.84% | 13.04M | Sydney | |||
| 6.48 | 6.56 | 6.29 | +0.180 | +2.86% | 2.73M | Sydney | |||
| 3.52 | 3.61 | 3.41 | -0.04 | -1.12% | 419.62K | Sydney | |||
| 26.88 | 26.975 | 26.72 | -0.060 | -0.22% | 13.93M | Sydney | |||
| 35.55 | 36.29 | 34.77 | +1.05 | +3.04% | 1.85M | Sydney | |||
| 0.07 | 0.00 | 0.00 | -0.002 | -2.78% | 11.94M | Sydney | |||
| 11.83 | 12.09 | 11.67 | +0.42 | +3.68% | 3.39M | Sydney | |||
| 0.002 | 0.00 | 0.00 | 0.000 | 0.00% | 0.00 | Sydney |
Analytica Limited is engaged in the design, development and supply of Class I and II medical devices. The Company's segments include Medical devices and Corporate. The Medical devices segment's products include PeriCoach (Perineometer), ELF-2 and AutoStart burette. The Company's lead product is the PeriCoach System, an e-health treatment system for women suffering from stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone application. The device evaluates activity in pelvic floor muscles. The information is transmitted to a smartphone application and can be loaded to PeriCloud where physicians can monitor patient progress through Web portal. The Analytica Autostart Infusion System offers solution to regular monitoring and refilling of burettes in intravenous fluid infusion. The Autostart burette contains a float system that automatically restarts intra-venous (IV) fluid flow following infused delivery of the predetermined amount of a required medication.